eric topol glp 1 GLP-1 drugs have intrinsic potent anti-inflammatory action beyond their metabolic beneficial impact on glucose regulation and weight loss https://lnkd.in/gXC4Fehz | Topol, MD GLP-1 drugs have intrinsic potent

The Australia GLP-1 receptor agonist market size was valued at USD 570.49 million in 2025 and is expected to hit around USD 2,117.46 million by 2035, growing at a CAGR of 14.01% from 2026 to 2035.

There have been and continue to be advances in the GLP-1 pipeline.

Gastroparesis, also known as stomach paralysis, is a serious digestive condition in which the stomach muscles stop functioning normally

Non-Prescription Solutions

Creatine monohydrate is a safe, research-driven supplement that supports cellular energy, protein synthesis, and exercise performance to combat muscle catabolism

Yes, tirzepatide commonly causes acid indigestion (dyspepsia) as a gastrointestinal side effect